Similar articles for PMID: 15545307

Year	Number of Results
1980	2
1982	1
1984	1
1985	2
1986	2
1987	4
1988	2
1989	2
1990	2
1991	1
1992	3
1993	5
1995	2
1996	3
1997	2
1998	3
1999	3
2000	5
2001	4
2002	3
2003	3
2004	8
2005	7
2006	11
2007	11
2008	8
2009	4
2010	3
2011	5
2012	6
2013	5
2014	3
2015	5
2016	3
2017	5
2018	3
2019	2
2020	2
2021	2
2022	1
2023	1
2024	0

1

Pharmacokinetics, safety, and tolerability of R411, a dual alpha4beta1-alpha4beta7 integrin antagonist after oral administration at single and multiple once-daily ascending doses in healthy volunteers.

Hijazi Y, Welker H, Dorr AE, Tang JP, Blain R, Renzetti LM, Abbas R. Hijazi Y, et al. J Clin Pharmacol. 2004 Dec;44(12):1368-78. doi: 10.1177/0091270004270147. J Clin Pharmacol. 2004. PMID: 15545307 Clinical Trial.

2

Single-dose bioavailability of levetiracetam intravenous infusion relative to oral tablets and multiple-dose pharmacokinetics and tolerability of levetiracetam intravenous infusion compared with placebo in healthy subjects.

Ramael S, De Smedt F, Toublanc N, Otoul C, Boulanger P, Riethuisen JM, Stockis A. Ramael S, et al. Clin Ther. 2006 May;28(5):734-44. doi: 10.1016/j.clinthera.2006.05.004. Clin Ther. 2006. PMID: 16861095 Clinical Trial.

3

Pharmacokinetic and pharmacodynamic properties of multiple oral doses of sitagliptin, a dipeptidyl peptidase-IV inhibitor: a double-blind, randomized, placebo-controlled study in healthy male volunteers.

Bergman AJ, Stevens C, Zhou Y, Yi B, Laethem M, De Smet M, Snyder K, Hilliard D, Tanaka W, Zeng W, Tanen M, Wang AQ, Chen L, Winchell G, Davies MJ, Ramael S, Wagner JA, Herman GA. Bergman AJ, et al. Clin Ther. 2006 Jan;28(1):55-72. doi: 10.1016/j.clinthera.2006.01.015. Clin Ther. 2006. PMID: 16490580 Clinical Trial.

4

Pharmacokinetic and pharmacodynamic assessments of the dipeptidyl peptidase-4 inhibitor PHX1149: double-blind, placebo-controlled, single- and multiple-dose studies in healthy subjects.

O'Farrell AM, van Vliet A, Abou Farha K, Cherrington JM, Campbell DA, Li X, Hanway D, Li J, Guler HP. O'Farrell AM, et al. Clin Ther. 2007 Aug;29(8):1692-705. doi: 10.1016/j.clinthera.2007.08.005. Clin Ther. 2007. PMID: 17919550 Clinical Trial.

5

Clinical pharmacokinetics and tolerability of dotarizine in healthy subjects after single and multiple oral administration.

Farré M, Roset PN, Llorente M, Márquez M, Albet C, Pérez JA, Herrero E, Ortíz JA. Farré M, et al. Methods Find Exp Clin Pharmacol. 1997 Jun;19(5):343-50. Methods Find Exp Clin Pharmacol. 1997. PMID: 9379783 Clinical Trial.

6

Estimating mass balance for inhaled drugs in humans: an example with a VLA-4 antagonist, IVL745.

Rohatagi S, Shah B, Zhang J, Zeng Z, Kirkesseli S, Jensen BK. Rohatagi S, et al. J Clin Pharmacol. 2004 Apr;44(4):348-58. doi: 10.1177/0091270004263465. J Clin Pharmacol. 2004. PMID: 15051741 Clinical Trial.

7

Two single-center, double-blind, randomized, placebo-controlled, phase I studies to investigate the tolerability and pharmacokinetics of CH-1504, an antifolate, in healthy male subjects.

Mant T, Jurcevic S, Szakacs C, Adams L, Boland J, Hewitt LA. Mant T, et al. Clin Ther. 2008 Jan;30(1):131-42. doi: 10.1016/j.clinthera.2008.01.017. Clin Ther. 2008. PMID: 18343249 Clinical Trial.

8

Pharmacokinetics and pharmacodynamics of epoetin delta in two studies in healthy volunteers and two studies in patients with chronic kidney disease.

Smith WB, Dowell JA, Pratt RD. Smith WB, et al. Clin Ther. 2007 Jul;29(7):1368-80. doi: 10.1016/j.clinthera.2007.07.014. Clin Ther. 2007. PMID: 17825688 Clinical Trial.

9

Randomized, crossover, single-blind, placebo-controlled, human pharmacology clinical trial with desoxypeganine, a new cholinesterase and selective MAO-A inhibitor: multiple-dose pharmacokinetics.

Algorta J, Pena MA, Alvarez A, Maraschiello C, Maruhn D, Windisch M, Mucke HA. Algorta J, et al. Int J Clin Pharmacol Ther. 2009 Jul;47(7):483-90. Int J Clin Pharmacol Ther. 2009. PMID: 19640356 Clinical Trial.

10

Absolute bioavailability of sitagliptin, an oral dipeptidyl peptidase-4 inhibitor, in healthy volunteers.

Bergman A, Ebel D, Liu F, Stone J, Wang A, Zeng W, Chen L, Dilzer S, Lasseter K, Herman G, Wagner J, Krishna R. Bergman A, et al. Biopharm Drug Dispos. 2007 Sep;28(6):315-22. doi: 10.1002/bdd.560. Biopharm Drug Dispos. 2007. PMID: 17575559 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

135 results

Results by year